Hypertrophic Cardiomyopathy secondary to Tacrolimus in a kidney
transplant patient: A case report and focused review of the literature
- Guillermo Hernández Silva,
- Ricardo Giovanni Puerto Chaparro ,
- Javier Álvaro Martínez Melo,
- Cristian Orlando Porras Bueno
, - Javier Eduardo Martínez Rodríguez ,
- Sharon Julieth González Trillos
Ricardo Giovanni Puerto Chaparro
Fundación Oftalmológica de Santander
Author ProfileJavier Álvaro Martínez Melo
Universidad Autónoma de Bucaramanga
Author ProfileCristian Orlando Porras Bueno
Universidad Autónoma de Bucaramanga
Author ProfileJavier Eduardo Martínez Rodríguez
Instituto del Corazón de Bucaramanga
Author ProfileSharon Julieth González Trillos
Universidad Autónoma de Bucaramanga
Author ProfileAbstract
In receptors of solid organ transplant, calcineurin inhibitors has
become a pillar of immunosuppressive treatment. Several case reports
have shown hypertrophic and dilated cardiomyopathy as a side effect of
tacrolimus. We present the case of a woman receptor of a kidney
transplant who developed hypertrophic cardiomyopathy due to Tacrolimus.25 Apr 2022Submitted to Clinical Case Reports 26 Apr 2022Submission Checks Completed
26 Apr 2022Assigned to Editor
10 May 2022Reviewer(s) Assigned
29 May 2022Review(s) Completed, Editorial Evaluation Pending
02 Jun 2022Editorial Decision: Revise Minor
24 Jun 20221st Revision Received
25 Jun 2022Submission Checks Completed
25 Jun 2022Assigned to Editor
25 Jun 2022Review(s) Completed, Editorial Evaluation Pending
03 Jul 2022Reviewer(s) Assigned
22 Jul 2022Editorial Decision: Revise Minor
27 Aug 20222nd Revision Received
30 Aug 2022Submission Checks Completed
30 Aug 2022Assigned to Editor
30 Aug 2022Review(s) Completed, Editorial Evaluation Pending
01 Sep 2022Editorial Decision: Revise Minor
20 Sep 20223rd Revision Received
21 Sep 2022Submission Checks Completed
21 Sep 2022Assigned to Editor
21 Sep 2022Review(s) Completed, Editorial Evaluation Pending
15 Oct 2022Editorial Decision: Accept
